Transplant Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Monash Cardiovascular Research Centre, Monash University, Melbourne, Vic, Australia.
Clin Transplant. 2021 Mar;35(3):e14192. doi: 10.1111/ctr.14192. Epub 2020 Dec 29.
Predicted heart mass (PHM) equations have been proposed as an alternative method for size matching in heart transplantation. We assessed association between donor-recipient size mismatch, defined using PHM equations, and survival post-heart transplant in the United Kingdom. Data from all adult patients who received a heart transplant between 1995 and 2017 were obtained from the United Kingdom Transplant Registry. PHM was calculated using published equations. Primary outcome was 1-year survival post-heart transplantation. Recipients of undersized organs had reduced 1-year survival (HR 1.31, 95% CI 1.03-1.67, p = .03). Oversizing had no impact on survival (HR 0.99, 95% CI 0.78-1.26, p = .96). Gender mismatching had no impact on survival in the cohort matched by PHM (HR 1.12, 95% CI 0.86-1.47, p = .4). In recipients without pulmonary hypertension, undersizing by PHM had no impact on 1-year survival (HR 0.95, 95% CI 0.61-1.49, p = .83). In recipients with pulmonary hypertension, oversizing donor RV by using PHM RV equation (PHM ) results in improved survival at 1 year (HR 0.65, 95% CI 0.5-0.83, p = .001). In conclusion, receiving an organ undersized by PHM was associated with decreased 1-year survival. Subgroup analyses demonstrated that undersizing only impacted survival in recipients with pulmonary hypertension and that these recipients had improved outcomes if they received an organ with an RV oversized by >10% by PHM .
预测的心脏质量(PHM)方程已被提出作为心脏移植中大小匹配的替代方法。我们评估了在英国,使用 PHM 方程定义的供体-受体大小不匹配与心脏移植后生存之间的关系。从英国移植登记处获得了 1995 年至 2017 年间接受心脏移植的所有成年患者的数据。使用已发表的方程计算 PHM。主要结局是心脏移植后 1 年的生存率。接受小器官的患者 1 年生存率降低(HR 1.31,95%CI 1.03-1.67,p=0.03)。供体器官过大对生存没有影响(HR 0.99,95%CI 0.78-1.26,p=0.96)。在按 PHM 匹配的队列中,性别不匹配对生存没有影响(HR 1.12,95%CI 0.86-1.47,p=0.4)。在没有肺动脉高压的患者中,PHM 测量的小器官大小对 1 年生存率没有影响(HR 0.95,95%CI 0.61-1.49,p=0.83)。在患有肺动脉高压的患者中,使用 PHM RV 方程(PHM)使 RV 供体过大可改善 1 年生存率(HR 0.65,95%CI 0.5-0.83,p=0.001)。总之,接受 PHM 测量的小器官会降低 1 年生存率。亚组分析表明,仅在患有肺动脉高压的患者中,小器官大小会影响生存率,如果接受 PHM 测量 RV 过大>10%的器官,这些患者的结局会更好。